Delving into the Latest Updates on Adipose-derived stromal vascular fraction cells(National Autonomous University of Nicaragua) with Synapse

Overview

Basic Info

Drug Type

Cell therapy

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas-

Active Indication-

Inactive Indication-

Originator Organization

National Autonomous University of Nicaragua

Active Organization-

Inactive Organization-

License Organization-

Drug Highest Phase-

First Approval Date-

Regulation-

This is an interventional study to treat 18 patients with chronic kidney disease of unknown cause (CKDu), formerly known as Mesoamerican nephropathy (MeN), with autologous adipose tissue-derived stromal vascular fraction (SVF) cells transplanted by intra-arterial injection both kidneys.
This study assesses: (1) safety and tolerability, (2) preliminary evidence of efficacy, (3) exploratory evidence of clinical effects.

Start Date01 Jan 2018

Sponsor / Collaborator

National Autonomous University of Nicaragua

[+1]

100 Clinical Results associated with Adipose-derived stromal vascular fraction cells(National Autonomous University of Nicaragua)

Login to view more data

100 Translational Medicine associated with Adipose-derived stromal vascular fraction cells(National Autonomous University of Nicaragua)

Login to view more data

100 Patents (Medical) associated with Adipose-derived stromal vascular fraction cells(National Autonomous University of Nicaragua)

Login to view more data

100 Deals associated with Adipose-derived stromal vascular fraction cells(National Autonomous University of Nicaragua)

Login to view more data